+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-07-01Number of Pages: 85

Regenerative Medicine Market (Bone and Joint) (Technology – Stem Cell Therapy, Biomaterial and Tissue Engineering; Application - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019

Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. Technological advancement in tissue engineering and stem cell therapy is expected to drive the global market for regenerative medicine (bone and joint). Moreover, growing prevalence of bone and joint disorder has also accounted for the market growth of the global regenerative medicine (bone and joint). However, factors such as stringent regulatory compliance, ethical issues pertaining to stem cell therapy and post implantation rejection are expected to hinder the global market growth during the forecast period. The global regenerative medicine (bone and joint) market was valued at USD 2,589.5 million in 2012 and is expected to grow at a CAGR of 12.8% from 2013 to 2019, to reach an estimated value of USD 6,473.4 million by 2019. 

 

The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. Moreover, tissue engineering is expected to grow at the highest CAGR during the forecast period. 

 

In addition, the global market for regenerative medicine (bone and joint) is segmented based on application as bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. Autogenic bone application segment is expected to grow at the highest CAGR during the forecast period 2013 to 2019.  

 

North America was the largest market for regenerative medicine bone and joint application in 2012, accounting for largest market share of the total regenerative medicine (bone and joint) market. The regenerative medicine market in North America witnessed significant growth due to increasing demand of bone and joint reconstructive surgeries. Moreover, favorable government initiatives have also supported the growth of the regenerative medicine bone and joint application market in this region. European market was the second largest of the global market in 2012. Rising geriatric population in European Union is one of the major market drivers in this region as the geriatric group is more prone to suffer from arthritis. Moreover, extensive support and funding provided by European government for regenerative medicine would further accentuate the market growth in this region. 

  

Asia-Pacific was observed to be a promising market for regenerative medicine bone and joint application during the study period owing to the demand of bone graft substitute in this region. This region is considered as an emerging market and is estimated to grow at the highest CAGR from 2013 to 2019. Manufacturer of regenerative medicine bone and joint products are expanding their operation in Asian countries (India, China, Japan and South Korea) as these economies hold immense potential for regenerative medicine bone and joint application. For instance, in May 2013, Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian medical technology company. Sushrut Surgicals product portfolio includes trauma implants and instruments, spine and limb salvage products. This acquisition would expand and enhance the product offerings of Smith & Nephew and would also assist in capturing lucrative market share in Asia-Pacific region. In terms of key players the global regenerative medicine bone and joint application market is highly fragmented that comprises of DePuy Synthes, Inc. (HEALOS Bone Graft), Medtronic, Inc. (INFUSE Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute) and Zimmer Holdings, Inc (CopiOs Bone Void Filler). 

 

 

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Assumptions

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 

2.2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 

2.3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 and 2019 (Value %)

 

Chapter 3 Market Overview

3.1 Overview

3.2 Market Drivers

      3.2.1 Technological innovations in biomaterials, stem cell therapy and tissue engineering are fueling the development of regenerative medicine products

      3.2.2 Growing prevalence of bone and joint disorders demand the growth of regenerative medicine products

      3.2.3 Growing number of orthopedic surgeries fuels the growth of the global regenerative medicine (bone and joint) market

3.3 Restraints

      3.3.1 Regulatory constraints pose a threat to the development of regenerative medicine (bone and joint) market

      3.3.2 Ethical issues and post implantation infections are hindering overall market growth

3.4 Opportunities

      3.4.1 Capitalization on the potential presented by emerging markets in Asia Pacific

3.5 Porter’s Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market

      3.5.1 Bargaining power of suppliers

      3.5.2 Bargaining power of buyers

      3.5.3 Threat of new entrants

      3.5.4 Threat of substitutes

      3.5.5 Competitive rivalry

3.6 Competitive Landscape

      3.6.1 Market Share Analysis by Key Players, 2012 (Value %)

3.7 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography

 

Chapter 4 Regenerative Medicine (Bone and Joint) Market, by Technology

4.1 Introduction

      4.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 

4.2 Stem Cell Therapy

      4.2.1 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 

4.3 Biomaterials

      4.3.1 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 

4.4 Tissue Engineering

      4.4.1 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) 

 

Chapter 5 Regenerative Medicine (Bone and Joint) Market, by Applications

5.1 Overview

      5.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 

5.2 Bone Graft Substitutes

      5.2.1 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 

5.3 Osteoarticular Diseases

      5.3.1 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 

5.4 Allogeneic Bones

      5.4.1 Global Allogenic Bones Application Market Revenue, 2011 – 2019 (USD Million) 

5.5 Autogenic Bones

      5.5.1 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 

5.6 Others

      5.6.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million) 

 

Chapter 6 Regenerative Medicine (Bone and Joint) Market, by Geography

6.1 Overview

      6.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 

6.2 North America

      6.2.1 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

6.3 Europe

      6.3.1 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

6.4 Asia-Pacific

      6.4.1 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

6.5 Rest of the World (RoW) 

      6.5.1 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

 

Chapter 7 Recommendations

7.1 Market Strategy for Success

      7.1.1 Rigorous research and development initiatives for innovative products

      7.1.2 Investing in emerging economies

7.2 Barriers and Future Assumptions

      7.2.1 Ethical issues pertaining to stem cell therapy hampering market growth

 

Chapter 8 Company Profiles

8.1 Anika Therapeutics, Inc. 

      8.1.1 Company Overview

      8.1.2 Financial Overview

      8.1.3 Product Portfolio

      8.1.4 Business Strategies

      8.1.5 Recent Developments

8.2 Arthrex, Inc. 

      8.2.1 Company Overview

      8.2.2 Financial Overview

      8.2.3 Product Portfolio

      8.2.4 Business Strategies

      8.2.5 Recent Developments

8.3 Baxter International, Inc. 

      8.3.1 Company Overview

      8.3.2 Financial Overview

      8.3.3 Product Portfolio

      8.3.4 Business Strategies

      8.3.5 Recent Developments

8.4 CONMED Corporation

      8.4.1 Company Overview

      8.4.2 Financial Overview

      8.4.3 Product Portfolio

      8.4.4 Business Strategies

      8.4.5 Recent Developments

8.5 DePuy Synthes, Inc. 

      8.5.1 Company Overview

      8.5.2 Financial Overview

      8.5.3 Product Portfolio

      8.5.4 Business Strategies

      8.5.5 Recent Developments

8.6 Medtronic, Inc. 

      8.6.1 Company Overview

      8.6.2 Financial Overview

      8.6.3 Product Portfolio

      8.6.4 Business Strategies

      8.6.5 Recent Developments

8.7 Smith & Nephew plc

      8.7.1 Company Overview

      8.7.2 Financial Overview

      8.7.3 Product Portfolio

      8.7.4 Business Strategies

      8.7.5 Recent Developments

8.8 Stryker Corporation

      8.8.1 Company Overview

      8.8.2 Financial Overview

      8.8.3 Product Portfolio

      8.8.4 Business Strategies

      8.8.5 Recent Developments

8.9 Zimmer Holdings, Inc. 

      8.9.1 Business Overview

      8.9.2 Financial Overview

      8.9.3 Product Portfolio

      8.9.4 Business Strategies

      8.9.5 Recent Developments

List of Figures

 

FIG. 1 Regenerative Medicine (Bone and Joint): Market Segmentation

FIG. 2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 

FIG. 3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 & 2019 (Value %)

FIG. 4 Porter’s Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market

FIG. 5 Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %)

FIG. 6 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 Value (%)

FIG. 7 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 

FIG. 8 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 

FIG. 9 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) 

FIG. 10 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 11 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 12 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 13 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 14 Global Others Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 15 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 16 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 17 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 18 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 19 Anika Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 20 Baxter International, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 21 Conmed Corporation: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 22 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (USD Million) 

FIG. 23 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 24 Smith & Nephew PLC: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 25 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 26 Zimmer Holdings. Inc,: Annual Revenue, 2011 – 2013 (USD Million) 

List of Tables

 

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 

TABLE 3 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 

TABLE 4 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 

TABLE 5 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 

Regenerative medicine is an emerging field in the healthcare industry concerned with the repair, replacement, and regeneration of damaged human tissue and organs. This includes damage from age-related degeneration, congenital defects, accidents, or diseases. Due to its vital contribution, regenerative medicine is becoming widely popular in the treatment of neurological, cardiovascular, musculoskeletal, and orthopedic conditions. Bone and joint conditions are among the leading applications of regenerative medicine. The viability of several synthetic alternatives to bones and joints is one of the key points that have driven investment in regenerative medicine in the recent past. 

The report presents a detailed summary of the historical development trajectory exhibited by the global regenerative medicine market and explains the market’s present condition through industry-standard analytical tools. A solid analysis of the market’s statistics is used to derive reliable forecasts regarding the development of the market in the coming years. According to the report, the global regenerative medicine market is expected to reach a valuation of US$6.5 bn by the end of 2019. 

Global Regenerative Medicine Market: Trends and Opportunities 

The increasing incidence of bone and joint diseases and injuries, brought about by the chronic damage done by the unhealthy lifestyle of most urban consumers and the rising number of vehicular and sports accidents, is the key driver for the global bone and joint regenerative medicine market. The sedentary lifestyle and chronically unhealthy diets of many urban individuals leave them prone to diseases that weaken or damage the bones, leading to a greater demand for orthopedic implants. 

While synthetic alternatives to bones and tissues are being developed at a steady rate, biobased alternatives such as stem cell therapy and tissue engineering have enjoyed a rapid emergence in the last few years. The ability of stem cells to develop into multiple types of human cells makes them vital in the treatment of several types of diseases. Stem cells are being intensively researched at present to maximize the scope of their use, and their use is likely to become increasingly important to the regenerative medicine market over the coming years. However, the biomaterials segment is likely to remain the leading contributor to the global regenerative medicine market in the near future. 

On the other hand, ethical objections to the use of stem cells have held back their widespread use and have also led to some restrictions on research into their utility in medicine. This is a key restraint on the overall regenerative medicine market, since stem cells are likely to be a crucial part of the future of the market. 

Global Regenerative Medicine Market: Geographical Segmentation 

Regionally, North America is the key contributor to the global regenerative medicine market due to the presence of several leading market players in the region, which has led to the latest advances in the field becoming easily available to patients. The well-funded R&D environment in the U.S. is also a key driver for the North America bone and joint regenerative medicine market, which is likely to remain a dominant regional market for regenerative medicine in the coming years. 

Asia Pacific is likely to emerge as a leading regional market for bone and joint regenerative medicine in the coming years. The increasing patient pool of bone and joint conditions and the steady rise in healthcare expenditure in Asia Pacific are vital in ensuring sustained growth of the Asia Pacific regenerative medicine market in the coming years. Many key multinational players in the regenerative medicine market have identified Asia Pacific as a high-potential market for the future and have accordingly taken steps to expand their presence in the region. 

Key players examined in the report include Smith & Nephew plc, Anika Therapeutics Inc., DePuy Synthes Inc., Baxter International Inc., Stryker Corporation, Medtronic Inc., Arthrex Inc., Zimmer Holdings Inc., and CONMED Corporation. 

Global Regenerative Medicine (Bone and Joint) Market by Technology

  • Biomaterials
  • Stem Cells
  • Tissue Engineering 

Global Regenerative Medicine (Bone and Joint) Market by Application

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Allogeneic Bones
  • Autogenic Bones 

Global Regenerative Medicine (Bone and Joint) Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World


 
 
Back To Top